BRIEF-XtalPi & PharmaEngine Hit Milestone as PRMT5 Inhibitor PEP08 Gets Trial Nod
Reuters
Sep 09
BRIEF-XtalPi & PharmaEngine Hit Milestone as PRMT5 Inhibitor PEP08 Gets Trial Nod
Sept 9 (Reuters) - XtalPi Holdings Ltd 2228.HK:
XTALPI AI DRUG DISCOVERY COLLABORATION REACHES MILESTONE AS PHARMAENGINE'S NOVEL PRMT5 INHIBITOR PEP08 RECEIVES CLINICAL TRIAL APPROVALS
Source text: ID:nPn2myz5ka
Further company coverage: 2228.HK
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.